New Key Statistics Module, Z-Score and F-Score
NAS:YMAB Key Ratios
Market Cap $ M | 668.43 |
Enterprise Value $ M | 580.70 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 6.61 |
Price/Sales | 7.85 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 84.00 |
EPS (TTM) $ | -0.49 |
Beneish M-Score | -1.14 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 15.80 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -22.62 |
EV-to-EBITDA | -23.29 |
PEG | -- |
Shares Outstanding M | 43.78 |
Net Margin (%) | -25.26 |
Operating Margin % | -30.27 |
Pre-tax Margin (%) | -24.60 |
Quick Ratio | 5.27 |
Current Ratio | 5.52 |
ROA % (ttm) | -16.04 |
ROE % (ttm) | -20.49 |
ROIC % (ttm) | -109.96 |
Dividend Yield % | -- |
Altman Z-Score | 10.77 |
Piotroski F-Score | 5.00 |
Positive ROA | N |
Positive CFROA | N |
Higher ROA y-y | Y |
Cash flow > Earnings | N |
Lower Leverage y-y | Y |
Higher Current Ratio y-y | Y |
Less Shares Outstanding y-y | Y |
Gross Margin Increase y-y | N |
Higher Asset Turnover y-y | Y |
YMAB Number of Guru Trades
YMAB Volume of Guru Trades
Gurus Latest Trades with NAS:YMAB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:YMAB is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Y-mAbs Therapeutics Inc Insider Transactions
No Available Data
News about NAS:YMAB
Total 0- 1